Turning the Corner: Patient-Focused Drug Development for Hyperhidrosis
It’s Time for Everyone Affected by Hyperhidrosis to Speak Up & Speak Out
This is a watershed moment for hyperhidrosis. The International Hyperhidrosis Society hosted a Patient-Focused Drug Development meeting in Washington, DC on November 13, 2017 designed to ensure that those affected by hyperhidrosis can make their voices – and needs -- heard by treatment developers, healthcare providers, and regulatory professionals from the U.S. Food and Drug Administration (FDA). If you’ve ever wanted a better way to control your sweating – and to stop sweating from controlling your life – it’s time to speak up - OPEN COMMENT PERIOD NEEDS YOUR INPUT NOW.